Kelly Shi
Stock Analyst at Jefferies
(3.84)
# 1,978
Out of 5,152 analysts
231
Total ratings
43.8%
Success rate
6%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kelly Shi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IBRX ImmunityBio | Reiterated: Buy | $8 → $14 | $6.70 | +108.96% | 6 | Oct 14, 2026 | |
| AVBP ArriVent BioPharma | Reiterated: Buy | $35 → $18 | $10.90 | +65.14% | 5 | Oct 6, 2026 | |
| INSM Insmed | Reiterated: Buy | $230 → $219 | $119.80 | +82.80% | 6 | Dec 18, 2025 | |
| PTCT PTC Therapeutics | Reiterated: Buy | $63 → $77 | $60.23 | n/a | 13 | Oct 28, 2025 | |
| IMCR Immunocore Holdings | Initiated Coverage: Buy | $48 | $27.51 | n/a | 1 | Aug 24, 2025 | |
| VRDN Viridian Therapeutics | Initiated Coverage: Buy | $44 | $30.12 | n/a | 1 | Aug 24, 2025 | |
| ZLAB Zai Lab | Initiated Coverage: Buy | $52 | $22.11 | n/a | 1 | Aug 24, 2025 | |
| ASND Ascendis Pharma | Reiterated: Buy | $233 → $235 | $270.33 | n/a | 10 | Jul 29, 2025 | |
| COGT Cogent Biosciences | Reiterated: Buy | $20 → $28 | $27.81 | n/a | 5 | Jul 7, 2025 | |
| KYMR Kymera Therapeutics | Reiterated: Buy | $59 → $64 | $121.13 | n/a | 6 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $82 | $117.80 | n/a | 13 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 | $8.56 | n/a | 6 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $6.87 | n/a | 3 | Jun 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $44 | $10.50 | n/a | 9 | May 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $91 | $16.25 | n/a | 37 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ¥5,100 | ¥6,897 | n/a | 1 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 → $6 | $0.6711 | n/a | 2 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1 | $0.015 | n/a | 1 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 → $30 | $19.82 | n/a | 2 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $56 → $42 | $3.11 | n/a | 9 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $286 | $403.60 | n/a | 17 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 → $40 | $10.46 | n/a | 4 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $10 | $1.37 | n/a | 2 | Jan 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $11 → $52 | $5.43 | n/a | 5 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $73 → $86 | $159.82 | n/a | 4 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $18 → $14 | $1.79 | n/a | 2 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $107 → $23 | $12.00 | n/a | 2 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $10.79 | n/a | 10 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $6.10 | n/a | 6 | Nov 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $26 → $3.5 | $1.82 | n/a | 3 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $13 | $1.06 | n/a | 6 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $3.77 | n/a | 1 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $120 → $7 | $6.40 | n/a | 3 | Jul 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.00 | $5.33 | n/a | 1 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $15 → $6 | $1.04 | n/a | 3 | Jun 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $14 | $2.48 | n/a | 5 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 → $5 | $0.9031 | n/a | 4 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $36 | $1.06 | n/a | 1 | Feb 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $8 | $2.50 | n/a | 4 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $1.03 | n/a | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $7 | $0.6652 | n/a | 2 | Oct 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $9.07 | n/a | 1 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 → $23 | $0.273 | n/a | 2 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $52 | $13.99 | n/a | 1 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $53 | $0.6959 | n/a | 2 | May 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $27 | $3.81 | n/a | 1 | Apr 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $63 | $1.36 | n/a | 1 | Apr 13, 2021 |
ImmunityBio
Oct 14, 2026
Reiterated: Buy
Price Target: $8 → $14
Current: $6.70
Upside: +108.96%
ArriVent BioPharma
Oct 6, 2026
Reiterated: Buy
Price Target: $35 → $18
Current: $10.90
Upside: +65.14%
Insmed
Dec 18, 2025
Reiterated: Buy
Price Target: $230 → $219
Current: $119.80
Upside: +82.80%
PTC Therapeutics
Oct 28, 2025
Reiterated: Buy
Price Target: $63 → $77
Current: $60.23
Upside: n/a
Immunocore Holdings
Aug 24, 2025
Initiated Coverage: Buy
Price Target: $48
Current: $27.51
Upside: n/a
Viridian Therapeutics
Aug 24, 2025
Initiated Coverage: Buy
Price Target: $44
Current: $30.12
Upside: n/a
Zai Lab
Aug 24, 2025
Initiated Coverage: Buy
Price Target: $52
Current: $22.11
Upside: n/a
Ascendis Pharma
Jul 29, 2025
Reiterated: Buy
Price Target: $233 → $235
Current: $270.33
Upside: n/a
Cogent Biosciences
Jul 7, 2025
Reiterated: Buy
Price Target: $20 → $28
Current: $27.81
Upside: n/a
Kymera Therapeutics
Jun 25, 2025
Reiterated: Buy
Price Target: $59 → $64
Current: $121.13
Upside: n/a
Jun 16, 2025
Reiterated: Buy
Price Target: $75 → $82
Current: $117.80
Upside: n/a
Jun 5, 2025
Reiterated: Buy
Price Target: $43
Current: $8.56
Upside: n/a
Jun 4, 2025
Reiterated: Buy
Price Target: $19
Current: $6.87
Upside: n/a
May 31, 2025
Reiterated: Buy
Price Target: $44
Current: $10.50
Upside: n/a
May 13, 2025
Reiterated: Buy
Price Target: $91
Current: $16.25
Upside: n/a
May 8, 2025
Reiterated: Buy
Price Target: ¥5,100
Current: ¥6,897
Upside: n/a
Apr 4, 2025
Reiterated: Buy
Price Target: $24 → $6
Current: $0.6711
Upside: n/a
Mar 25, 2025
Downgraded: Sell
Price Target: $1
Current: $0.015
Upside: n/a
Feb 27, 2025
Reiterated: Buy
Price Target: $40 → $30
Current: $19.82
Upside: n/a
Feb 25, 2025
Reiterated: Buy
Price Target: $56 → $42
Current: $3.11
Upside: n/a
Feb 21, 2025
Reiterated: Buy
Price Target: $286
Current: $403.60
Upside: n/a
Feb 10, 2025
Reiterated: Buy
Price Target: $58 → $40
Current: $10.46
Upside: n/a
Jan 21, 2025
Reiterated: Buy
Price Target: $13 → $10
Current: $1.37
Upside: n/a
Jan 7, 2025
Upgraded: Buy
Price Target: $11 → $52
Current: $5.43
Upside: n/a
Dec 20, 2024
Reiterated: Buy
Price Target: $73 → $86
Current: $159.82
Upside: n/a
Dec 16, 2024
Rated: Buy
Price Target: $18 → $14
Current: $1.79
Upside: n/a
Dec 13, 2024
Reiterated: Buy
Price Target: $107 → $23
Current: $12.00
Upside: n/a
Dec 11, 2024
Reiterated: Buy
Price Target: $65
Current: $10.79
Upside: n/a
Nov 18, 2024
Rated: Buy
Price Target: $20
Current: $6.10
Upside: n/a
Nov 15, 2024
Downgraded: Hold
Price Target: $26 → $3.5
Current: $1.82
Upside: n/a
Nov 12, 2024
Reiterated: Buy
Price Target: $11 → $13
Current: $1.06
Upside: n/a
Aug 13, 2024
Initiated Coverage: Buy
Price Target: $21
Current: $3.77
Upside: n/a
Jul 19, 2024
Downgraded: Hold
Price Target: $120 → $7
Current: $6.40
Upside: n/a
Jun 10, 2024
Reiterated: Buy
Price Target: $7.00
Current: $5.33
Upside: n/a
Jun 10, 2024
Rated: Buy
Price Target: $15 → $6
Current: $1.04
Upside: n/a
Mar 4, 2024
Reiterated: Buy
Price Target: $11 → $14
Current: $2.48
Upside: n/a
Feb 9, 2024
Reiterated: Buy
Price Target: $75 → $5
Current: $0.9031
Upside: n/a
Feb 4, 2024
Initiated Coverage: Buy
Price Target: $36
Current: $1.06
Upside: n/a
Jan 5, 2024
Reiterated: Buy
Price Target: $27 → $8
Current: $2.50
Upside: n/a
Dec 14, 2022
Reiterated: Buy
Price Target: $14
Current: $1.03
Upside: n/a
Oct 5, 2022
Reiterated: Buy
Price Target: $27 → $7
Current: $0.6652
Upside: n/a
Aug 15, 2022
Initiated Coverage: Buy
Price Target: $20
Current: $9.07
Upside: n/a
Jan 18, 2022
Rated: Buy
Price Target: $25 → $23
Current: $0.273
Upside: n/a
Aug 3, 2021
Initiated Coverage: Buy
Price Target: $52
Current: $13.99
Upside: n/a
May 20, 2021
Rated: Buy
Price Target: $53
Current: $0.6959
Upside: n/a
Apr 20, 2021
Initiated Coverage: Buy
Price Target: $27
Current: $3.81
Upside: n/a
Apr 13, 2021
Rated: Buy
Price Target: $63
Current: $1.36
Upside: n/a